Market Cap 18.17M
Revenue (ttm) 14.60M
Net Income (ttm) -10.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -70.89%
Debt to Equity Ratio 0.42
Volume 2,859
Avg Vol 21,902
Day's Range N/A - N/A
Shares Out 9.61M
Stochastic %K 71%
Beta 0.91
Analysts Sell
Price Target $3.60

Company Profile

LiqTech International, Inc., a clean technology company, manufactures and markets specialized filtration products and systems in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. It operates through three segments: Water, Ceramics, and Plastics. The company also manufactures and sells silicon carbide ceramic filtration technologies for liquid and gas purification; and diesel particulate filters for exhaust emission control solutions to the verified retrofit and the original eq...

Industry: Pollution & Treatment Controls
Sector: Industrials
Phone: 45 31 31 59 41
Website: liqtech.com
Address:
Industriparken 22C, Ballerup, Denmark
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jul. 17 at 6:53 PM
$LIQT its been awhile since we've seen this
0 · Reply
mag_x
mag_x Jul. 13 at 6:57 PM
$LIQT and now? What's going on?
0 · Reply
mag_x
mag_x Jul. 12 at 12:20 AM
$LIQT what's going on
1 · Reply
RollingDollars
RollingDollars Jun. 27 at 7:33 PM
0 · Reply
RollingDollars
RollingDollars Jun. 27 at 7:33 PM
0 · Reply
meagain424
meagain424 Jun. 25 at 3:30 PM
$LIQT 😁🚀🚀🚀🚀🚀
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 25 at 1:03 PM
$LIQT OMG! A sale!
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 16 at 11:05 AM
WATCHLIST JUN 16 2025. $AIOT Powerfleet Expands Deployment Of Advanced AI Video Safety Solution With EverDriven Technologies $LLY Eli Lilly Announces That The Highest Approved Doses Of Zepbound (Tirzepatide)—12.5 mg And 15 mg—Will Soon Be Available In Single-dose Vials For $499 Per Month Through LillyDirect's Self Pay Pharmacy Solutions And The Zepbound Self Pay Journey Program $LIQT Ascendiant Capital Maintains Buy on LiqTech International, Raises Price Target to $3.6 $CNTB Connect Biopharma Presents Clinical Data Supporting Rademikibart, Anti-Interleukin-4-Receptor Alpha Antibody At EAACI 2025 Annual Congress $TTE TotalEnergies Partners With Petronas In Multiple Blocks Offshore Malaysia And One Block Offshore Indonesia
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 11:00 AM
Ascendiant Capital has updated their rating for LiqTech International ( $LIQT ) to Buy with a price target of 3.6.
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 3 at 6:32 PM
$LIQT been racking up the big volume days lately. News around the corner Fei?
1 · Reply
Latest News on LIQT
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jul. 17 at 6:53 PM
$LIQT its been awhile since we've seen this
0 · Reply
mag_x
mag_x Jul. 13 at 6:57 PM
$LIQT and now? What's going on?
0 · Reply
mag_x
mag_x Jul. 12 at 12:20 AM
$LIQT what's going on
1 · Reply
RollingDollars
RollingDollars Jun. 27 at 7:33 PM
0 · Reply
RollingDollars
RollingDollars Jun. 27 at 7:33 PM
0 · Reply
meagain424
meagain424 Jun. 25 at 3:30 PM
$LIQT 😁🚀🚀🚀🚀🚀
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 25 at 1:03 PM
$LIQT OMG! A sale!
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 16 at 11:05 AM
WATCHLIST JUN 16 2025. $AIOT Powerfleet Expands Deployment Of Advanced AI Video Safety Solution With EverDriven Technologies $LLY Eli Lilly Announces That The Highest Approved Doses Of Zepbound (Tirzepatide)—12.5 mg And 15 mg—Will Soon Be Available In Single-dose Vials For $499 Per Month Through LillyDirect's Self Pay Pharmacy Solutions And The Zepbound Self Pay Journey Program $LIQT Ascendiant Capital Maintains Buy on LiqTech International, Raises Price Target to $3.6 $CNTB Connect Biopharma Presents Clinical Data Supporting Rademikibart, Anti-Interleukin-4-Receptor Alpha Antibody At EAACI 2025 Annual Congress $TTE TotalEnergies Partners With Petronas In Multiple Blocks Offshore Malaysia And One Block Offshore Indonesia
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 11:00 AM
Ascendiant Capital has updated their rating for LiqTech International ( $LIQT ) to Buy with a price target of 3.6.
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 3 at 6:32 PM
$LIQT been racking up the big volume days lately. News around the corner Fei?
1 · Reply
RollingDollars
RollingDollars Jun. 3 at 2:48 PM
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen May. 14 at 12:35 PM
$LIQT circling back to the margins issue — Fei better not be selling any more PureFlow systems at cost. We’re here to make money. I get that the first one was a reference install to help future sales, but that excuse has a shelf life. Starting now, every unit should carry real margin.
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen May. 14 at 12:17 PM
$LIQT you've pulled me back in my queen. They hit the high end of their Q1 revenue guide at $4.6M (+36% QoQ, +9% YoY). Margins still a drag — gross margin came in at 2.7%, but that's a step up from last quarter’s negative margin. Q2 guidance of $4.8M–$5.2M gets them within striking distance of the $5.5M–$6.0M breakeven target. You get me for another quarter, Fei.
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 14 at 12:07 PM
$LIQT Q1 2025 shows sequential revenue growth of 36% to $4.6M, with China JV already securing marine scrubber orders. Guidance suggests continued momentum (Q2 rev $4.8-5.2M). Bullish on expanding oil/gas and lithium brine pilots, but that 2.7% gross margin stings. Cash position solid at $10.4M. Conference call today - let's see if the street buys the turnaround narrative. https://www.prnewswire.com/news-releases/liqtech-international-announces-first-quarter-2025-financial-results-302454416.html
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen May. 7 at 1:23 AM
$LIQT I'm losing faith Fei
0 · Reply
mag_x
mag_x Apr. 21 at 11:14 PM
$LIQT Feiiiii
0 · Reply
Mustang8
Mustang8 Apr. 9 at 6:08 PM
$LIQT looks good
0 · Reply
JarvisFlow
JarvisFlow Apr. 7 at 11:00 AM
Ascendiant Capital updates rating for LiqTech Intl ( $LIQT ) to Buy, target set at 3.2 → 3.4.
0 · Reply
erevnon
erevnon Apr. 7 at 10:50 AM
Ascendiant Capital reiterates LiqTech Intl $LIQT at Buy and raises the price target from $3.2 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
mikesterz7
mikesterz7 Mar. 28 at 12:20 PM
$LIQT LiqTech International reported Q4 2024 financial results with revenue of $3.4 million, up 37% sequentially but down 13% year-over-year. Full-year 2024 revenue decreased 19% to $14.6 million, with a net loss of $(10.3) million compared to $(8.6) million in 2023. The company implemented cost reduction strategies including a 10% headcount reduction, 10% salary cuts for senior management, and 50% reduction in board compensation. The break-even target is now set at $5.5-6.0 million quarterly revenue. Key highlights include a record commercial order for PureFlow™ mobile units, three operational pilot units for various markets including lithium harvesting, and new swimming pool system deliveries. Q1 2025 guidance projects revenue between $4.3-4.7 million, representing 26-38% sequential growth.
0 · Reply
DARKP00L
DARKP00L Mar. 28 at 12:13 PM
$LIQT 08:12 on Mar. 28 2025 LiqTech International Implemented Cost Reduction Strategy That Includes 10% Reduction In Headcount, 10% Reduction In Base Salaries For Senior Management, 50% Reduction In Cash Compensation For The Board Of Directors In 2025 #tradeideas
0 · Reply
DARKP00L
DARKP00L Mar. 28 at 12:10 PM
$LIQT 08:10 on Mar. 28 2025 LiqTech International Sees Q1 2025 Revenue Between $4.3M-$4.7M Vs. $4.90M Estimate #tradeideas
0 · Reply